MedPath

MSD PHARMA (SINGAPORE) PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

67

HSA:63
NMPA:4

Drug Approvals

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Product Name
捷诺达
Approval Number
国药准字J20171013
Approval Date
May 29, 2019
NMPA

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Product Name
捷诺达
Approval Number
国药准字J20171012
Approval Date
May 29, 2019
NMPA

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Product Name
捷诺达
Approval Number
H20140774
Approval Date
Mar 21, 2019
NMPA

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Product Name
捷诺达
Approval Number
H20140775
Approval Date
Mar 21, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.